SERA Earnings Date: Nov 4, 2026 (Estimated) — Sera Prognostics, Inc.
NASDAQ · Healthcare · Medical Devices
Updated
When is SERA's next earnings date?
Sera Prognostics, Inc. (SERA) is expected to report Q3 2026 earnings on Wednesday, November 4, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.14 on revenue of $75,000.
How did SERA do in its last earnings report?
In its most recent report on Aug 12, 2026 (Q2 2026), Sera Prognostics, Inc. posted EPS of -$0.18 versus the -$0.15 estimate, a miss of 12.5%. Revenue was $30,000 against a $71,375 estimate. The stock's 1-day post-earnings move was -0.5%.
How much does SERA stock move after earnings?
SERA beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 3.6% (up or down) in the day after earnings.
About Sera Prognostics, Inc.
Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, the company is cultivating a portfolio of potential tests for various other pregnancy-related conditions, such as preeclampsia, predicting time-to-birth at a molecular level, gestational diabetes mellitus, restricted fetal growth, stillbirth, and postpartum depression. Established in 2008, the organization's main operations are based in Salt Lake City, Utah.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | Q2 2026 | -0.15 | -0.18 | -12.50% | $30,000 | ❌ Miss | -0.49% | -1.49% | +0.49% |
| 2026-05-06 | Q1 2026 | -0.17 | -0.17 | +0.00% | $14,000 | ➖ Inline | +6.08% | -12.15% | +26.52% |
| 2026-03-18 | Q4 2025 | -0.18 | -0.16 | +11.11% | $10,000 | ✅ Beat | -6.28% | +4.19% | +20.42% |
| 2025-11-13 | Q3 2025 | -0.20 | -0.16 | +20.00% | $16,000 | ✅ Beat | +0.34% | +6.10% | +14.58% |
| 2025-08-06 | Q2 2025 | -0.23 | -0.16 | +30.43% | $17,000 | ✅ Beat | -5.45% | -16.36% | +21.45% |
| 2025-03-19 | Q4 2024 | -0.23 | -0.25 | -8.70% | $24,000 | ❌ Miss | -5.07% | -5.07% | -17.87% |
| 2024-08-07 | Q2 2024 | -0.26 | -0.25 | +3.85% | $24,000 | ✅ Beat | +0.14% | -7.30% | -2.03% |
| 2024-05-08 | Q1 2024 | -0.27 | -0.25 | +7.41% | $0 | ✅ Beat | +5.27% | -9.35% | -11.94% |
Showing last 8 quarters.